Celgene Corp (CELG) Tops Q3 EPS by 2c; Bumps Guidance Higher
Tweet
Share
E-mailGet Alerts CELG Hot Sheet
Price: $108.24 --0%
Financial Fact:
Selling, general and administrative: 698M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Selling, general and administrative: 698M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Celgene Corp (NASDAQ: CELG) reported Q3 EPS of $1.29, $0.02 better than the analyst estimate of $1.27. Revenue for the quarter came in at $1.42 billion versus the consensus estimate of $1.41 billion.
Celgene Corp sees FY2012 EPS of $4.85-4.90, versus prior guidance of $4.80-4.85 and the consensus of $4.88. Celgene Corp sees FY2012 revenue of $5.45-5.55 billion, versus prior guidance of $5.4-5.6 billion and the consensus of $5.5 billion.
For earnings history and earnings-related data on Celgene Corp (CELG) click here.
Celgene Corp sees FY2012 EPS of $4.85-4.90, versus prior guidance of $4.80-4.85 and the consensus of $4.88. Celgene Corp sees FY2012 revenue of $5.45-5.55 billion, versus prior guidance of $5.4-5.6 billion and the consensus of $5.5 billion.
For earnings history and earnings-related data on Celgene Corp (CELG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
